I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.

Alnylam Pharma Poised to Shoot Higher

The biopharmaceutical company shows bullish charts that signal a breakout to new all-time highs. The charts and indicators are bullish,

No Predictions, But 2 Picks for the Second Half of 2020

BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.

Cutting Edge Biotech Cytokinetics Could Double in Price

Let's check the charts and indicators.

Covid-19 Complications, Grocery Store-y, More on Moderna: Market Recon

Plus, a closer look at Thursday's late-day rally and at actions impacting the nation's big banks.

I've Got the Perfect Prescription for Your Portfolio

Here's how to play CVS Health and avoid most negative investing side effects.

Cannabis Companies Eyeing How Plant Could Help Autism Symptoms

After finding success in treatment for epilepsy and other conditions, some in the industry are focusing on autism spectrum disorder.

9 Bargain Stocks to Watch in Asia's Worst-Performing Market

Indonesian stocks have done poorly this year, but these nine stocks could rate attention if investors rediscover the market.

Ventas Dividend Cut Could Portend Pressure on Payouts of Senior Living REITs

Covid-19 is inflicting its greatest toll on the elderly, and that is impacting companies that care for older adults.

Will Investors Clean Up With Clorox?

The disinfecting-wipe maker continues to rally strongly toward higher price targets.